CHANNELS

Subscribe to the InfoTech eNewsletter

infoTECH News

TMCNet:  Arrowhead to Present at Barclays Global Healthcare Conference

[March 10, 2014]

Arrowhead to Present at Barclays Global Healthcare Conference

PASADENA, Calif. --(Business Wire)--

Arrowhead Research Corporation (NASDAQ: ARWR), a biopharmaceutical company developing targeted RNAi therapeutics, today announced that President and CEO, Christopher Anzalone, Ph.D., will present at the Barclays Global Healthcare Conference on Thursday, March 13, 2014 at 8:00 a.m. EDT at the Loews Hotel in Miami, Florida.

A live webcast of the presentation can be accessed by visiting the News & Events section of the company's website, http://www.arrowheadresearch.com/pesentations. A replay will also be archived on the website.

About Arrowhead Research Corporation

Arrowhead Research Corporation is a biopharmaceutical company developing targeted RNAi therapeutics. The company is leveraging its proprietary drug delivery technologies to develop targeted drugs based on the RNA interference mechanism that efficiently silence disease-causing genes. Arrowhead technologies also enable partners to create peptide-drug conjugates that specifically home to cell types of interest while sparing off-target tissues. Arrowhead's pipeline includes clinical programs in chronic hepatitis B virus and partner-based programs in obesity and oncology.

For more information please visit http://www.arrowheadresearch.com, or follow us on Twitter (News - Alert) @ArrowRes. To be added to the Company's email list to receive news directly, please send an email to ir@arrowres.com.


[ InfoTech Spotlight's Homepage ]


blog comments powered by Disqus

FOLLOW US

Subscribe to InfoTECH Spotlight eNews

InfoTECH Spotlight eNews delivers the latest news impacting technology in the IT industry each week. Sign up to receive FREE breaking news today!
FREE eNewsletter